BioSpace News Archive

In 2022, DeoBioSciences is continuing its first equity crowdfunding offering to retail and institutional investors at Netcapital.com to finance further testing of its anti-cancer drug candidate in special xenograft models that can predict, with up to 98% reliability, the future clinical success or failure of a drug candidate before human trials begin. (www.netcapital.com/companies/deobiosciences).

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced its schedule for presentations at the 25th Annual North American Neuromodulation Society meeting, taking place January 13-15, 2022 in Orlando, Florida.

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth-quarter and full-year 2021 results on Wednesday, February 23, 2022 at 1 p.m. London time (8 a.m. Eastern Time).

MiNK Therapeutics announced that Dr. Jennifer Buell, President and CEO of MiNK, will participate in a fireside chat at the B. Riley Securities Virtual Oncology Investor Conference on January 27th, 2022, at 12:00 pm ET.

Todos Medical, Ltd. today announced that topline results from the Tollovir™ Phase 2 clinical trial for the treatment of hospitalized COVID-19 patients will be announced the morning of January 27th, 2022.

Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that it is starting a “Compassionate Use Clinical Trial” for treatment of Parkinson’s disease.

Curta, a growing provider of health economics and outcomes research products and services, today announced that Sean D. Sullivan , BSPharm, PhD, Scott Ramsey , MD, PhD, David Veenstra, PharmD, PhD, and Josh Carlson, MPH, PhD have joined as partners.

Unique real-world data platform integrating proprietary, regulatory-grade, patient-generated health data.

Magnetic Insight has installed a localized magnetic theranostic system at Johns Hopkins University to support an National Institutes of Health-funded project to develop precision-guided magnetic fluid hyperthermia.

The article “Tracking adoptive T cell immunotherapy using magnetic particle imaging” has been published in the journal Nanotheranostics (2021, vol 5.). This promising research was concluded using the MOMENTUM™ imager from Magnetic Insight to track the T cells inside a mouse migrating to a brain tumor.